Cullinan Therapeutics Inc (CGEM)
15.66
-0.13
(-0.82%)
USD |
NASDAQ |
Nov 14, 10:39
Cullinan Therapeutics Price to Book Value: 1.384 for Nov. 14, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 1.395 |
| November 12, 2024 | 1.415 |
| November 11, 2024 | 1.526 |
| November 08, 2024 | 1.415 |
| November 07, 2024 | 1.376 |
| November 06, 2024 | 1.456 |
| November 05, 2024 | 1.412 |
| November 04, 2024 | 1.406 |
| November 01, 2024 | 1.394 |
| October 31, 2024 | 1.374 |
| October 30, 2024 | 1.433 |
| October 29, 2024 | 1.495 |
| October 28, 2024 | 1.427 |
| October 25, 2024 | 1.410 |
| October 24, 2024 | 1.401 |
| October 23, 2024 | 1.379 |
| October 22, 2024 | 1.409 |
| October 21, 2024 | 1.431 |
| October 18, 2024 | 1.482 |
| October 17, 2024 | 1.535 |
| October 16, 2024 | 1.556 |
| October 15, 2024 | 1.435 |
| October 14, 2024 | 1.434 |
| October 11, 2024 | 1.433 |
| October 10, 2024 | 1.402 |
| Date | Value |
|---|---|
| October 09, 2024 | 1.365 |
| October 08, 2024 | 1.423 |
| October 07, 2024 | 1.417 |
| October 04, 2024 | 1.444 |
| October 03, 2024 | 1.422 |
| October 02, 2024 | 1.457 |
| October 01, 2024 | 1.481 |
| September 30, 2024 | 1.479 |
| September 27, 2024 | 1.519 |
| September 26, 2024 | 1.528 |
| September 25, 2024 | 1.444 |
| September 24, 2024 | 1.559 |
| September 23, 2024 | 1.469 |
| September 20, 2024 | 1.604 |
| September 19, 2024 | 1.585 |
| September 18, 2024 | 1.522 |
| September 17, 2024 | 1.523 |
| September 16, 2024 | 1.496 |
| September 13, 2024 | 1.586 |
| September 12, 2024 | 1.557 |
| September 11, 2024 | 1.588 |
| September 10, 2024 | 1.574 |
| September 09, 2024 | 1.612 |
| September 06, 2024 | 1.588 |
| September 05, 2024 | 1.584 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7132
Minimum
May 18 2023
11.68
Maximum
Mar 10 2021
1.936
Average
1.392
Median
Price to Book Value Benchmarks
| CEL-SCI Corp | 4.283 |
| AIM ImmunoTech Inc | 2.574 |
| IGC Pharma Inc | 3.484 |
| NovaBay Pharmaceuticals Inc | -- |
| Protalix BioTherapeutics Inc | 3.435 |
Price to Book Value Related Metrics
| Price | 15.66 |
| Earnings Yield | -19.54% |
| Market Cap | 907.91M |